Reducing Agent-Assisted Excessive Galvanic Replacement Mediated Seed-Mediated Synthesis of Porous Gold Nanoplates and Highly Efficient Gene-Thermo Cancer Therapy.
Seounghun KangKyunglee KangHyun HuhHyungjun KimSung-Jin ChangTae Jung ParkKi Soo ChangDal-Hee MinHongje JangPublished in: ACS applied materials & interfaces (2017)
Porous Au nanoplates (pAuNPs) were manufactured by a reducing agent-assisted galvanic replacement reaction on Ag nanoplates using a seed-mediated synthetic approach. Two core additives, poly(vinylpyrrolidone) and l-ascorbic acid, prevented fragmentation and proceeded secondary growth. By controlling the concentration of the additives and the amount of replacing ion AuCl4-, various nanostructures including nanoplates with holes, nanoframes, porous nanoplates, and bumpy nanoparticles with unity and homogeneity were synthesized. The present synthetic method is advantageous, because it can be used to manufacture pAuNPs with ease, robustness, and convenience. The prepared pAuNPs exhibited a highly efficient photothermal conversion effect and cargo loading capacity on exposed surfaces by Au-thiol linkage. By using dual cargo mixed loading of the hepatitis C virus (HCV) targeting gene drug DNAzyme and cell-penetrating peptide TAT onto the surface of the pAuNPs and photothermal conversion-mediated hyperthermic treatment, successful gene-thermo therapy against HCV genomic human hepatocarcinoma cells were demonstrated.
Keyphrases
- highly efficient
- hepatitis c virus
- cancer therapy
- copy number
- drug delivery
- genome wide
- human immunodeficiency virus
- photodynamic therapy
- endothelial cells
- induced apoptosis
- sensitive detection
- dna methylation
- cell therapy
- single cell
- signaling pathway
- ionic liquid
- body mass index
- stem cells
- oxidative stress
- gene expression
- staphylococcus aureus
- metal organic framework
- living cells
- escherichia coli
- cell cycle arrest
- quantum dots
- pseudomonas aeruginosa
- smoking cessation
- endoplasmic reticulum stress
- hiv infected
- antiretroviral therapy